Tradewinds Capital Management’s Tiziana Life Sciences TLSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $395 | Hold |
250
| – | – | ﹤0.01% | 566 |
|
|
2025
Q1 | $270 | Hold |
250
| – | – | ﹤0.01% | 615 |
|
|
2024
Q4 | $175 | Hold |
250
| – | – | ﹤0.01% | 637 |
|
|
2024
Q3 | $240 | Hold |
250
| – | – | ﹤0.01% | 586 |
|
|
2024
Q2 | $230 | Hold |
250
| – | – | ﹤0.01% | 561 |
|
|
2024
Q1 | $114 | Hold |
250
| – | – | ﹤0.01% | 533 |
|
|
2023
Q4 | $140 | Hold |
250
| – | – | ﹤0.01% | 451 |
|
|
2023
Q3 | $165 | Hold |
250
| – | – | ﹤0.01% | 473 |
|
|
2023
Q2 | $171 | Hold |
250
| – | – | ﹤0.01% | 448 |
|
|
2023
Q1 | $273 | Hold |
250
| – | – | ﹤0.01% | 435 |
|
|
2022
Q4 | $150 | Hold |
250
| – | – | ﹤0.01% | 490 |
|
|
2022
Q3 | $0 | Hold |
250
| – | – | ﹤0.01% | 501 |
|
|
2022
Q2 | $0 | Hold |
250
| – | – | ﹤0.01% | 766 |
|
|
2022
Q1 | $0 | Hold |
250
| – | – | ﹤0.01% | 840 |
|
|
2021
Q4 | $0 | Hold |
250
| – | – | ﹤0.01% | 813 |
|
|
2021
Q3 | $0 | Hold |
250
| – | – | ﹤0.01% | 807 |
|
|
2021
Q2 | $1K | Hold |
250
| – | – | ﹤0.01% | 744 |
|
|
2021
Q1 | $1K | Buy |
250
+16
| +7% | +$64 | ﹤0.01% | 716 |
|
|
2020
Q4 | $0 | Buy |
234
+64
| +38% | – | ﹤0.01% | 727 |
|
|
2020
Q3 | $1K | Buy |
170
+65
| +62% | +$382 | ﹤0.01% | 639 |
|
|
2020
Q2 | $0 | Buy |
105
+5
| +5% | – | ﹤0.01% | 716 |
|
|
2020
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 738 |
|
|
2019
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 704 |
|
|
2019
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 649 |
|
|
2019
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 638 |
|
|
2019
Q1 | $0 | Buy |
100
+10
| +11% | – | ﹤0.01% | 651 |
|
|
2018
Q4 | $0 | Buy |
+90
| New | – | ﹤0.01% | 682 |
|